In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
University of Southern California
University of Southern California
Valo Therapeutics Oy
NextPoint Therapeutics, Inc.
National Cancer Institute (NCI)
BioEclipse Therapeutics
Celgene
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Valerio Therapeutics
Valerio Therapeutics
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center